TrialFrontiers in pharmacology2026

Favorable safety outcomes of a perioperative propranolol and etodolac regimen in cancer patients in four randomized controlled trials.

Nahida Sakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.